Zhejiang Paullorna Medical Technology Co., Ltd.

2020 is a landmark year in the development of domestic medical protection products. As a representative product of Paulona's patented protective mask, the domestic brand network has achieved an unprecedented market share. On the one hand, thanks to the domestic investment in product research and development in recent years, the brand has the most cost-effective protective mask in terms of product performance and after-sales service; on the other hand, the whole society has continued to support the development of domestic medical protective masks. The rise and the support of national policies have given great help to national brands.
With the acceleration of the aging of the population, the improvement of people's living standards, and the gradual promotion of new diagnosis and treatment technologies, the terminal demand of the medical industry will continue to maintain rapid growth. The areas that are encouraged by the policy support, especially domestic medical enterprises capable of achieving import substitution, There will be huge development space in the future.
The way out for Chinese medical companies depends on research and development. Once the standards are raised, it is difficult for others to meet the requirements. Many R & D technologies are now in foreign hands. Many electronic medical devices in China cannot even produce core components. Some companies are assembly companies. The future development path of Chinese medical devices is to go high-end and produce completely independently.